cyclic nigerosylnigerose

Networked: 2 relevant articles (1 outcomes, 1 trials/studies)

1.	Jian, Hou Jian: 1 article (01/2020)
2.	Katsumata, Emiko: 1 article (01/2020)
3.	Mizote, Akiko: 1 article (01/2020)
4.	Muhomah, Teresia Aluoch: 1 article (01/2020)
5.	Nishino, Naoki: 1 article (01/2020)
6.	Tsuruta, Takeshi: 1 article (01/2020)

1.	Colitis 01/01/2020 - "Cyclic nigerosylnigerose ameliorates DSS-induced colitis with restoration of goblet cell number and increase in IgA reactivity against gut microbiota in mice."
2.	Inflammation (Inflammations) 01/01/2023 - "This study evaluates the effect of cyclic nigerosylnigerose (CNN), a dietary fiber that prevents gut inflammation and promotes IgA coating of gut bacteria, on the above-mentioned HFD-induced disorders. " 01/01/2023 - "Cyclic Nigerosylnigerose Attenuates High-Fat Diet-Induced Fat Deposition, Colonic Inflammation, and Abnormal Glucose Metabolism and Modifies Gut Immunoglobulin a Reactivity to Commensal Bacteria."